Cysticercosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1560B69.0B69.1B69.8
Who is this for?
Show terms as
1FDA treatments1Active trials45Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cysticercosis is a parasitic tissue infection caused by the larval cysts (cysticerci) of the pork tapeworm, Taenia solium. It is not a genetic disease but rather an acquired infectious condition. Humans become infected by ingesting T. solium eggs, typically through fecal-oral transmission from contaminated food, water, or contact with an infected individual who harbors the adult tapeworm. Once ingested, the larvae can migrate to various tissues throughout the body, forming cysts most commonly in the brain (neurocysticercosis), skeletal muscles, subcutaneous tissues, and eyes (ocular cysticercosis). Neurocysticercosis (NCC) is the most clinically significant form and is the leading cause of acquired epilepsy in endemic regions worldwide. Key symptoms depend on the location, number, and stage of the cysts and include seizures, chronic headaches, increased intracranial pressure (hydrocephalus), cognitive decline, focal neurological deficits, and meningitis. Ocular cysticercosis can cause visual disturbances, eye pain, and vision loss. Subcutaneous and muscular cysticercosis may present as painless nodules under the skin. Cysticercosis is endemic in many low- and middle-income countries in Latin America, sub-Saharan Africa, and Asia, where sanitation infrastructure is limited and pigs are raised in close contact with humans. Treatment depends on the form and severity of disease. Antiparasitic medications such as albendazole and praziquantel are used to kill viable cysts, often in combination with corticosteroids (such as dexamethasone) to manage the inflammatory response triggered by cyst degeneration. Antiepileptic drugs are used to control seizures. Surgical intervention may be necessary for cases involving hydrocephalus, large cysts, or intraventricular or spinal cysts. Prevention strategies focus on improved sanitation, meat inspection, health education, and mass treatment programs in endemic areas.

Clinical phenotype terms— hover any for plain English:

Intracranial cystic lesionHP:0010576Abnormal meningeal morphologyHP:0010651Abnormal skeletal muscle morphologyHP:0011805Abnormal subarachnoid space morphologyHP:0012703Arachnoid cystHP:0100702CSF lymphocytic pleiocytosisHP:0200149Increased anti-parasite IgE antibody levelHP:0410234
Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

4 events
Dec 2025The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis

Cephas Health Research Initiative Inc, Ibadan, Nigeria — NA

TrialNOT YET RECRUITING
Dec 2024Oxfendazole in Mild Parenchymal Brain Cysticercosis

Universidad Peruana Cayetano Heredia — PHASE2, PHASE3

TrialNOT YET RECRUITING
Jun 2024Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

R-Evolution Worldwide S.r.l. Impresa Sociale — PHASE4

TrialNOT YET RECRUITING
Oct 1985Natural History of Treated Neurocysticercosis and Long-Term Outcomes

National Institute of Allergy and Infectious Diseases (NIAID)

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Albenza

Albendazole· Impax Laboratories, LLC

Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Natural History of Treated Neurocysticercosis and Long-Term Outcomes
Actively Recruiting
PI: Elise M O'Connell, M.D. (National Institute of Allergy and Infectious Disea) · Sites: Bethesda, Maryland · Age: 399 yrs

Specialists

Showing 25 of 45View all specialists →
HM
Hector H. Garcia, MD
Specialist
PI on 1 active trial
JM
Javier A. Bustos, MD
Specialist
PI on 1 active trial
TM
Theodore E. Nash, MD
BETHESDA, MD
Specialist
PI on 1 active trial
HP
Hélène Carabin, DVM PhD
Specialist
PI on 1 active trial
GP
Giveson Zulu, PhD
Specialist
PI on 1 active trial
SP
Sarah Gabriel, PhD
Specialist
PI on 1 active trial
EM
E. Javier Pretell, MD
Specialist
PI on 1 active trial
CP
Chummy S. Sikasunge, PhD
Specialist
PI on 1 active trial
CP
Chummy Sikasunge, PhD
Specialist
PI on 1 active trial
HP
Hector H. Garcia, MD, PhD
Specialist
PI on 2 active trials
PM
Pingli Wang, MD
Specialist
PI on 1 active trial
EM
Evans K. Mwape, MSc
Specialist
PI on 1 active trial
BP
Bernard J Ngowi, MD, PhD
Specialist
PI on 1 active trial
AP
Amar Pujari
Specialist
1 Cysticercosis publication
KB
Karthika Bhaskaran
Specialist
1 Cysticercosis publication
VS
Veronika Schmidt
Specialist
3 Cysticercosis publications
AW
Andrea S Winkler
DURHAM, NC
Specialist
3 Cysticercosis publications
EF
Eric M Fèvre
Specialist
2 Cysticercosis publications
GG
Gregorio Gonzalez-Alcaide
Specialist
2 Cysticercosis publications
NS
Nestor Sosa
ALBUQUERQUE, NM
Specialist
2 Cysticercosis publications
IB
Isabel Belinchon-Romero
Specialist
2 Cysticercosis publications
JR
Jose-Manuel Ramos-Rincon
Specialist
2 Cysticercosis publications
CS
Chummy S Sikasunge
Specialist
2 Cysticercosis publications
KM
Kabemba E Mwape
Specialist
2 Cysticercosis publications
MS
Martin C Simuunza
Specialist
2 Cysticercosis publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Albenza(Albendazole)Impax Laboratories, LLC

Travel Grants

No travel grants are currently matched to Cysticercosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open CysticercosisForum →

No community posts yet. Be the first to share your experience with Cysticercosis.

Start the conversation →

Latest news about Cysticercosis

Disease timeline:

New recruiting trial: Natural History of Treated Neurocysticercosis and Long-Term Outcomes

A new clinical trial is recruiting patients for Cysticercosis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cysticercosis

What is Cysticercosis?

Cysticercosis is a parasitic tissue infection caused by the larval cysts (cysticerci) of the pork tapeworm, Taenia solium. It is not a genetic disease but rather an acquired infectious condition. Humans become infected by ingesting T. solium eggs, typically through fecal-oral transmission from contaminated food, water, or contact with an infected individual who harbors the adult tapeworm. Once ingested, the larvae can migrate to various tissues throughout the body, forming cysts most commonly in the brain (neurocysticercosis), skeletal muscles, subcutaneous tissues, and eyes (ocular cysticerco

Are there clinical trials for Cysticercosis?

Yes — 1 recruiting clinical trial is currently listed for Cysticercosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Cysticercosis?

25 specialists and care centers treating Cysticercosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Cysticercosis?

1 patient support program are currently tracked on UniteRare for Cysticercosis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.